A practical reference on AOD-9604: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2025-11-27 and is reviewed periodically as new material appears.
Regulatory interest in AOD-9604 increased after high-profile anti-doping cases involving peptide products. In some cases, the substance was supplied under alternative names or in compounded preparations, complicating traceability. Sports tribunals and anti-doping panels have discussed whether the peptide was explicitly banned at the time of use, leading to clarifications by the World Anti-Doping Agency. For consumers and researchers, the legal status can vary by jurisdiction, and products marketed as research chemicals may lack independent quality verification.
AOD-9604 is listed as a prohibited substance in sport by the World Anti-Doping Agency. It falls under the peptide hormones, growth factors, related substances, and mimetics class on the prohibited list. Anti-doping organizations treat its presence in an athlete's sample as an adverse finding unless a therapeutic use exemption applies. The prohibition reflects concerns about performance enhancement in competitive settings and the difficulty of distinguishing exogenous peptide use from endogenous hormone fragments.
Detection of AOD-9604 in biological samples relies on analytical techniques capable of distinguishing a small synthetic peptide from related endogenous sequences. Liquid chromatography coupled with tandem mass spectrometry is commonly used for confirmatory analysis. Sample preparation may involve immunoaffinity enrichment or solid-phase extraction to concentrate the peptide. Because the molecule is small and may be present at low concentrations, assay sensitivity and specificity are ongoing analytical challenges. Laboratories also validate methods against reference materials when available.
In laboratory settings, AOD-9604 is commonly supplied as a lyophilized powder and stored cold to limit degradation. Reconstituted solutions are typically kept refrigerated or frozen, depending on the buffer and concentration, and protected from repeated freeze-thaw cycles. Stability can be influenced by pH, temperature, and the presence of proteases. Purity is usually assessed by high-performance liquid chromatography and mass spectrometry. These practices support reproducibility, but they do not imply safety or efficacy for any human use.
Regulatory status: AOD-9604 is not approved as a therapeutic drug in the United States, European Union, or other major markets. It is listed by the World Anti-Doping Agency as a prohibited substance in sport, specifically under growth hormone fragments. Many jurisdictions restrict its sale for human consumption. Products marketed online may not meet pharmaceutical quality standards. The legal status varies by country and often depends on whether the material is presented as a research chemical, supplement, or drug.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Prohibited in sport | Listed by WADA under peptide hormones |
| WADA class | S2 | Peptide hormones, growth factors, related substances, and mimetics |
| Approved therapeutic use | Not established | Clinical research did not lead to broad marketing approval |
| Common detection method | LC-MS/MS | Liquid chromatography-tandem mass spectrometry |
| Sample preparation | Extraction and enrichment | Immunoaffinity or solid-phase extraction may be used |
Identity and purity are usually assessed with reversed-phase high-performance liquid chromatography and mass spectrometry. Reversed-phase HPLC separates the peptide from related impurities and can estimate purity by ultraviolet absorbance, while mass spectrometry confirms the molecular mass and detects modifications. Peptide mapping, amino acid analysis, and disulfide mapping may be used when the sequence or disulfide arrangement must be verified. Because AOD9604 contains cysteine residues, oxidation and disulfide isomers are possible quality concerns in synthetic batches.
Quality varies among research-grade suppliers, so certificates of analysis and independent testing are important for verification. A typical certificate reports purity by HPLC, identity by mass spectrometry, appearance, and sometimes residual solvents or water content. AOD9604 is often sold as a research chemical not intended for human consumption, and labels can be inaccurate. Common misconceptions include treating the peptide as a form of growth hormone, assuming supplement status, or expecting approved-drug quality from unregulated products.
AOD9604 is commonly supplied as a white to off-white lyophilized powder. The powder is typically stored at -20 °C or below, protected from light and moisture, because peptides can degrade through oxidation, hydrolysis, or aggregation. If it is reconstituted for laboratory use, an appropriate aqueous buffer or solvent is chosen, and the solution is kept cold and handled to avoid repeated freeze-thaw cycles. These practices support stability but do not imply suitability for human use.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It is often described as hGH fragment 176-191. Research interest arose because it was designed to isolate possible effects on fat metabolism from other actions of growth hormone. It is not a full growth hormone molecule. Its development history includes early laboratory and animal studies followed by human trials. The peptide has been examined in laboratory, animal, and limited human studies.
The compound has been studied as a potential treatment for obesity and related metabolic conditions. Published trials have examined changes in body weight, fat mass, and safety markers over limited durations. Results have been mixed or modest, and no large-scale outcome trials are established. Regulatory agencies in several countries have not approved it as a therapeutic drug. Some commercial products have been marketed outside regulated pharmaceutical channels, which raises questions about quality and claims.
Mexico's initial neutrality in World War II was challenged by various geopolitical and economic considerations, such as its proximity to the United States, improved relations with the US as a result of President Franklin D. Roosevelt's Good Neighbor policy, and the need of the allied countries for Mexican oil for the war effort.
Overview: Contains a motivational overview of ODP, giving scoping, justification and explanation of key concepts, and an outline of the ODP architecture. It contains explanatory material on how the RM-ODP is to be interpreted and applied by its users, who may include standard writers and architects of ODP systems. Foundations: Contains the definition of the concepts and analytical framework for normalized description of (arbitrary) distributed processing systems. It introduces the principles of conformance to ODP standards and the way in which they are applied. In only 18 pages, this standard sets the basics of the whole model in a clear, precise and concise way. Architecture: Contains the specification of the required characteristics that qualify distributed processing as open. These are the constraints to which ODP standards must conform. This recommendation also defines RM-ODP viewpoints, subdivisions of the specification of a whole system, established to bring together those particular pieces of information relevant to some particular area of concern. Architectural Semantics: Contains a formalization of the ODP modeling concepts by interpreting many concepts in terms of the constructs of the different standardized formal description techniques.
=== mz5 === The mz5 format addresses the performance problems present in other XML based formats (such as the above ones). It uses mzML's ontology, but saves the data using the HDF5 backend for reduced storage space requirements and improved read/write speed.
Other fruits that can disperse via water are nipa palm and screw pine. Some fruits have evolved propulsive mechanisms that fling seeds substantial distances – perhaps up to 100 m (330 ft) in the case of the sandbox tree – via explosive dehiscence or other such mechanisms (see impatiens and squirting cucumber).
=== Freeze drying === Freeze drying is accomplished by lowering the pressure in a chamber containing the wood to a few millibars, while lowering the temperature of the chamber to below the eutectic point of the material. Heat is typically added slowly to the material to allow the water contained in the wood to sublimate directly into vapor, and be deposited on the sides of the vacuum chamber or in the cold trap through which the chamber is evacuated. Freeze drying through sublimation typically takes about 10 times the energy that is taken through evaporation of water by heat. In practice, freeze drying of wood can be accomplished by placing room temperature wood in a vacuum chamber that can be chilled to -30 degrees C or lower, evacuating the chamber to a few millibars, and at the same time cooling the chamber to a freezing temperature. The latent heat of the ice in the wood will come out through the water vapor, which will condense as ice on the inside of the chamber. After a few hours under vacuum and freezing conditions, the chamber is returned to normal pressure, the wood removed and bagged in plastic to keep water from condensing on it, and allowed to return to room temperature over a few hours to a day. The cycle is then repeated, each time the latent heat in the wood is removed through the water content in the wood sublimating and/or evaporating and condensing on the sides of the container and in the cold trap. The cycles are repeated until the moisture content of the wood is at a pre-determined acceptable level.
Sources: en.wikipedia.org
Substitution in position 4 of the benzyl affects analgesic potency in the following order: ethoxy > isopropyloxy > n-propyloxy > methoxy > methylthio > H/Cl/F > hydroxy. The most potent of the known compounds contain a nitro group in position 5. The replacement of benzimidazole with an indole has been known from studies conducted by Ciba AG since 1963.
Additionally, in many places, embalming is not done by specialist embalmers, but rather by doctors, medical technicians or laboratory technicians who, while they have the required anatomical or chemical knowledge, are not trained specialists in this field. Today, embalming is a common practice in North America, Australia, New Zealand, Britain and Ireland, while it is much less frequent in many parts of Europe; most modern countries have embalming available in some manner.
Formaldehyde preserves or fixes tissue or cells. The process involves cross-linking of primary amino groups. The European Union has banned the use of formaldehyde as a biocide (including embalming) under the Biocidal Products Directive (98/8/EC) due to its carcinogenic properties. Countries with a strong tradition of embalming corpses, such as Ireland and other colder-weather countries, have raised concerns. Despite reports to the contrary, no decision on the inclusion of formaldehyde on Annex I of the Biocidal Products Directive for product-type 22 (embalming and taxidermist fluids) had been made as of September 2009. Formaldehyde-based crosslinking is exploited in ChIP-on-chip or ChIP-sequencing genomics experiments, where DNA-binding proteins are cross-linked to their cognate binding sites on the chromosome and analyzed to determine what genes are regulated by the proteins. Formaldehyde is also used as a denaturing agent in RNA gel electrophoresis, preventing RNA from forming secondary structures. A solution of 4% formaldehyde fixes pathology tissue specimens at about one millimeter per hour at room temperature.
AAV-mediated gene transfer of the full-length Mybpc3 (defined as "gene replacement") dose-dependently prevents the development of cardiac hypertrophy and dysfunction in homozygous Mybpc3-targeted knock-in mice. The dose-dependent expression of exogenous Mybpc3 was associated with the down-regulation of endogenous mutant Mybpc3. Additional expression of a sarcomeric protein is expected to replace partially or completely the endogenous protein level in the sarcomere, as it has been shown in transgenic mice expressing sarcomeric proteins.
Sources: en.wikipedia.org
Yes, the World Anti-Doping Agency classifies AOD-9604 as a prohibited peptide hormone and related substance. Its use by athletes is banned under the relevant anti-doping code.
Confirmatory detection typically uses liquid chromatography with mass spectrometry. Immunoassays may be used for screening, but mass spectrometry provides structural confirmation.
No widely approved therapeutic indication exists for AOD-9604. It has been investigated in clinical studies, but regulatory approvals for general medical use are not established.
No major regulatory agency has approved AOD-9604 as a medicine. It is treated as an experimental peptide in research settings. Some countries restrict its sale or import.